According to filings with the U.S. Securities and Exchange Commission, Halda Therapeutics is raising up to $126,471,316.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Phillips played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Halda Therapeutics
At Halda Therapeutics we are a dynamic, innovative biotech startup. We are doing groundbreaking science located in state-of-the-art labs in Science Park in New Haven, which is adjacent to Yale Universitys Science Hill. Halda was founded by world renowned scientist, Professor Craig Crews, and we seek innovative solutions to solve complex drug discovery problems. Our research focuses on platform technologies to target cancer cells selectively, thereby creating the next frontier of life changing therapeutics for patients diagnosed with cancer. Halda is a bold company where collaboration, passion, and creativity thrive, which allows us to push the boundaries of drug discovery to identify better solutions.

To learn more about Halda Therapeutics, visit http://haldatherapeutics.com/
Halda Therapeutics Linkedin Page: https://www.linkedin.com/company/halda-therapeutics/

Contact:
Scott Phillips, Chief Executive Officer
860-655-8653
https://www.linkedin.com/in/scott-phillips-652941a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.